Literature DB >> 30767670

Pulmonary vascular mechanical consequences of ischemic heart failure and implications for right ventricular function.

Jennifer L Philip1,2, Thomas M Murphy1, David A Schreier1, Sydney Stevens3, Diana M Tabima1, Margie Albrecht3, Andrea L Frump3, Timothy A Hacker4, Tim Lahm3,5,6, Naomi C Chesler1,4.   

Abstract

Left heart failure (LHF) is the most common cause of pulmonary hypertension, which confers an increase in morbidity and mortality in this context. Pulmonary vascular resistance has prognostic value in LHF, but otherwise the mechanical consequences of LHF for the pulmonary vasculature and right ventricle (RV) remain unknown. We sought to investigate mechanical mechanisms of pulmonary vascular and RV dysfunction in a rodent model of LHF to address the knowledge gaps in understanding disease pathophysiology. LHF was created using a left anterior descending artery ligation to cause myocardial infarction (MI) in mice. Sham animals underwent thoracotomy alone. Echocardiography demonstrated increased left ventricle (LV) volumes and decreased ejection fraction at 4 wk post-MI that did not normalize by 12 wk post-MI. Elevation of LV diastolic pressure and RV systolic pressure at 12 wk post-MI demonstrated pulmonary hypertension (PH) due to LHF. There was increased pulmonary arterial elastance and pulmonary vascular resistance associated with perivascular fibrosis without other remodeling. There was also RV contractile dysfunction with a 35% decrease in RV end-systolic elastance and 66% decrease in ventricular-vascular coupling. In this model of PH due to LHF with reduced ejection fraction, pulmonary fibrosis contributes to increased RV afterload, and loss of RV contractility contributes to RV dysfunction. These are key pathologic features of human PH secondary to LHF. In the future, novel therapeutic strategies aimed at preventing pulmonary vascular mechanical changes and RV dysfunction in the context of LHF can be tested using this model. NEW & NOTEWORTHY In this study, we investigate the mechanical consequences of left heart failure with reduced ejection fraction for the pulmonary vasculature and right ventricle. Using comprehensive functional analyses of the cardiopulmonary system in vivo and ex vivo, we demonstrate that pulmonary fibrosis contributes to increased RV afterload and loss of RV contractility contributes to RV dysfunction. Thus this model recapitulates key pathologic features of human pulmonary hypertension-left heart failure and offers a robust platform for future investigations.

Entities:  

Keywords:  heart failure; pulmonary vascular remodeling; right ventricle dysfunction; secondary pulmonary hypertension; ventricular-vascular coupling

Mesh:

Year:  2019        PMID: 30767670      PMCID: PMC6580389          DOI: 10.1152/ajpheart.00319.2018

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  79 in total

1.  Pulmonary vascular resistance. A meaningless variable?

Authors:  Robert Naeije
Journal:  Intensive Care Med       Date:  2003-04       Impact factor: 17.440

2.  A simple distensible vessel model for interpreting pulmonary vascular pressure-flow curves.

Authors:  J H Linehan; S T Haworth; L D Nelin; G S Krenz; C A Dawson
Journal:  J Appl Physiol (1985)       Date:  1992-09

Review 3.  The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension.

Authors:  Harm J Bogaard; Kohtaro Abe; Anton Vonk Noordegraaf; Norbert F Voelkel
Journal:  Chest       Date:  2009-03       Impact factor: 9.410

4.  Hemodynamic stresses induce endothelial dysfunction and remodeling of pulmonary artery in experimental compensated heart failure.

Authors:  A Ben Driss; C Devaux; D Henrion; M Duriez; C Thuillez; B I Levy; J B Michel
Journal:  Circulation       Date:  2000-06-13       Impact factor: 29.690

Review 5.  Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.

Authors:  Anton Vonk-Noordegraaf; François Haddad; Kelly M Chin; Paul R Forfia; Steven M Kawut; Joost Lumens; Robert Naeije; John Newman; Ronald J Oudiz; Steve Provencher; Adam Torbicki; Norbert F Voelkel; Paul M Hassoun
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

6.  Imaging right ventricular function to predict outcome in pulmonary arterial hypertension.

Authors:  Melanie J Brewis; Alessandro Bellofiore; Rebecca R Vanderpool; Naomi C Chesler; Martin K Johnson; Robert Naeije; Andrew J Peacock
Journal:  Int J Cardiol       Date:  2016-05-13       Impact factor: 4.164

7.  Effective arterial elastance as index of arterial vascular load in humans.

Authors:  R P Kelly; C T Ting; T M Yang; C P Liu; W L Maughan; M S Chang; D A Kass
Journal:  Circulation       Date:  1992-08       Impact factor: 29.690

8.  Characterization of the isolated, ventilated, and instrumented mouse lung perfused with pulsatile flow.

Authors:  Rebecca R Vanderpool; Naomi C Chesler
Journal:  J Vis Exp       Date:  2011-04-29       Impact factor: 1.355

Review 9.  Evolving Concepts of Pulmonary Hypertension Secondary to Left Heart Disease.

Authors:  Bhavadharini Ramu; Thenappan Thenappan
Journal:  Curr Heart Fail Rep       Date:  2016-04

10.  Right ventricular ejection fraction: an indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease.

Authors:  J F Polak; B L Holman; J Wynne; W S Colucci
Journal:  J Am Coll Cardiol       Date:  1983-08       Impact factor: 24.094

View more
  9 in total

Review 1.  Hemodynamic assessment of diastolic function for experimental models.

Authors:  Leslie M Ogilvie; Brittany A Edgett; Jason S Huber; Mathew J Platt; Hermann J Eberl; Sohrab Lutchmedial; Keith R Brunt; Jeremy A Simpson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-03-27       Impact factor: 4.733

2.  Diaphragm weakness and proteomics (global and redox) modifications in heart failure with reduced ejection fraction in rats.

Authors:  Rachel C Kelley; Brian McDonagh; Babette Brumback; Glenn A Walter; Ravneet Vohra; Leonardo F Ferreira
Journal:  J Mol Cell Cardiol       Date:  2020-02-05       Impact factor: 5.000

Review 3.  Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies.

Authors:  Helen Christou; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-02-25       Impact factor: 4.733

Review 4.  Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.

Authors:  Jessica H Huston; Sanjiv J Shah
Journal:  Circ Res       Date:  2022-04-28       Impact factor: 23.213

Review 5.  Guidelines for in vivo mouse models of myocardial infarction.

Authors:  Merry L Lindsey; Keith R Brunt; Jonathan A Kirk; Petra Kleinbongard; John W Calvert; Lisandra E de Castro Brás; Kristine Y DeLeon-Pennell; Dominic P Del Re; Nikolaos G Frangogiannis; Stefan Frantz; Richard J Gumina; Ganesh V Halade; Steven P Jones; Rebecca H Ritchie; Francis G Spinale; Edward B Thorp; Crystal M Ripplinger; Zamaneh Kassiri
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-10-08       Impact factor: 5.125

Review 6.  Diagnosis and Treatment of Right Heart Failure in Pulmonary Vascular Diseases: A National Heart, Lung, and Blood Institute Workshop.

Authors:  Jane A Leopold; Steven M Kawut; Micheala A Aldred; Stephen L Archer; Ray L Benza; Michael R Bristow; Evan L Brittain; Naomi Chesler; Frances S DeMan; Serpil C Erzurum; Mark T Gladwin; Paul M Hassoun; Anna R Hemnes; Tim Lahm; Joao A C Lima; Joseph Loscalzo; Bradley A Maron; Laura Mercer Rosa; John H Newman; Susan Redline; Stuart Rich; Franz Rischard; Lissa Sugeng; W H Wilson Tang; Ryan J Tedford; Emily J Tsai; Corey E Ventetuolo; YouYang Zhou; Neil R Aggarwal; Lei Xiao
Journal:  Circ Heart Fail       Date:  2021-06-15       Impact factor: 10.447

7.  Reply to Tello et al.: Pending Right Heart Failure in Healthy Preterm-Born Subjects?

Authors:  Alessandro Bellofiore; Kara N Goss; Ashley Mulchrone; Naomi C Chesler
Journal:  Am J Respir Crit Care Med       Date:  2020-04-15       Impact factor: 21.405

8.  Impact of concurrent right ventricular myocardial infarction on outcomes among patients with left ventricular myocardial infarction.

Authors:  Huocheng Liao; Qiuyue Chen; Lin Liu; Sigan Zhong; Huazhao Deng; Chun Xiao
Journal:  Sci Rep       Date:  2020-02-03       Impact factor: 4.379

9.  An in-silico analysis of experimental designs to study ventricular function: A focus on the right ventricle.

Authors:  Mitchel J Colebank; Naomi C Chesler
Journal:  PLoS Comput Biol       Date:  2022-09-20       Impact factor: 4.779

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.